Jon Sudbø

Jon Sudbø's AcademicInfluence.com Rankings

Jon Sudbø

Medical

#439

World Rank

#604

Historical Rank

Dentistry

#51

World Rank

#72

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Jon Sudbø Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jon Sudbø is a Norwegian dentist, physician, and former medical researcher, who was exposed as a scientific fraudster in 2006. Over a period of several years, he fabricated results in the field of oncology which he published in leading medical journals. The article that led to his downfall, which was published in The Lancet, was based on 900 patients Sudbø had fabricated entirely. The editor of The Lancet described this as the biggest scientific fraud conducted by a single researcher ever.

(See a Problem?)

Jon Sudbø's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Gene-expression profiles in hereditary breast cancer. (2001) (840)
DNA content as a prognostic marker in patients with oral leukoplakia. (2001) (298)
Oral cancer prevention and the evolution of molecular-targeted drug development. (2005) (185)
The invasive front of carcinomas. The most important area for tumour prognosis? (1998) (132)
The influence of resection and aneuploidy on mortality in oral leukoplakia. (2004) (117)
Progress in determining the malignant potential of oral lesions. (2003) (110)
Retracted: The evolution of predictive oncology and molecular‐based therapy for oral cancer prevention (2005) (75)
RETRACTED: Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study (2005) (68)
beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. (2005) (66)
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. (2003) (63)
Novel management of oral cancer: a paradigm of predictive oncology. (2004) (57)
Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias. (2002) (55)
Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. (2001) (54)
Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals. (2003) (48)
New Algorithms Based on the Voronoi Diagram Applied in a Pilot Study on Normal Mucosa and Carcinomas (2000) (45)
Prognostic Value of Graph Theory-Based Tissue Architecture Analysis in Carcinomas of the Tongue (2000) (33)
RETRACTED: Molecular based treatment of oral cancer (2003) (29)
Corticopontine terminal fibres form small scale clusters and large scale lamellae in the cat (1997) (20)
Molecular based treatment of oral cancer. (2003) (20)
Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling. (2005) (18)
Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables. (2004) (14)
Retracted: Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies (2002) (13)
Retraction notice to 'Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions' [Oral Oncol. 39 (2003) 497-505]. (2007) (13)
COX-2 expression in striated muscle under physiological conditions. (2003) (11)
Caveats: Numerical Requirements in Graph Theory Based Quantitation of Tissue Architecture (2000) (9)
Diagnostic implications of p53 protein reactivity in nasal mucosa of nickel workers. (1997) (9)
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. (2001) (8)
[Digital image analysis in pathology--exemplified in prostatic cancer]. (2000) (5)
RETRACTED: When is an oral leukoplakia premalignant? (2002) (4)
Pathology in disgrace? (2002) (4)
When is an oral leukoplakia premalignant? (2002) (3)
Retraction notice to 'Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches' [Oral Oncol. 37 (2001) 558-565]. (2007) (3)
[Adverse effects of COX-2 inhibitors]. (2002) (1)
Non-steroidal anti-inflammatory drugs and the risk of oral cancer in current and former smokers - [REMOVED] (2005) (1)
[Biology and treatment options during the development of prostate cancer]. (2005) (1)
[Chemoprevention of oral cancer]. (2003) (1)
Non-Invasive Early Diagnosis of Oral Cavity Malignancies (2003) (1)
Retraction notice to 'Molecular based treatment of oral cancer' [Oral Oncol. 39 (2003) 749-758]. (2007) (1)
Prognosis in pre-malignant lesions (2005) (0)
Retraction notice to 'When is an oral leukoplakia premalignant?' [Oral Oncol. 38 (2002) 813-814]. (2007) (0)
Protection of research subjects. (2003) (0)
Long-term use of NSAID reduces the risk of oral cancer. (2004) (0)
Gross G enomic A berrations i n P recancers: C linical Implications o f a L ong-Term F ollow-Up S tudy i n O ral Erythroplakias (2002) (0)
[Chemoprevention: treatment of persons at high risk of cancer]. (2003) (0)
Chemoprevention of Oral Cancer Risk Assessment, Plausible Intervention, and Monitoring (0)
[DNA ploidy analysis--a possibility for early identification of patient with risk of oral cancer]. (2001) (0)
[Diagnosis and treatment of oral precancerous lesions]. (2001) (0)

This paper list is powered by the following services:

Other Resources About Jon Sudbø

en.wikipedia.org

What Schools Are Affiliated With Jon Sudbø?

Jon Sudbø is affiliated with the following schools:

University of Oslo